Global I.V. (Intravenous Fluid) Bags Market Outlook and Growth Opportunities 2025

Summary

According to APO Research, the global I.V. (Intravenous Fluid) Bags market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for I.V. (Intravenous Fluid) Bags is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for I.V. (Intravenous Fluid) Bags is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the I.V. (Intravenous Fluid) Bags market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for I.V. (Intravenous Fluid) Bags is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the I.V. (Intravenous Fluid) Bags market include Amcor, Baxter, Fresenius Kabi, Hospira (Pfizer), ICU Medical, Inc., JW Lifescience Corporation, Otsuka Pharmaceutical, SIPPEX and Wihuri Group, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for I.V. (Intravenous Fluid) Bags, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of I.V. (Intravenous Fluid) Bags, also provides the sales of main regions and countries. Of the upcoming market potential for I.V. (Intravenous Fluid) Bags, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the I.V. (Intravenous Fluid) Bags sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global I.V. (Intravenous Fluid) Bags market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for I.V. (Intravenous Fluid) Bags sales, projected growth trends, production technology, application and end-user industry.

I.V. (Intravenous Fluid) Bags Segment by Company

Amcor
Baxter
Fresenius Kabi
Hospira (Pfizer)
ICU Medical, Inc.
JW Lifescience Corporation
Otsuka Pharmaceutical
SIPPEX
Wihuri Group
B. Braun
I.V. (Intravenous Fluid) Bags Segment by Type

Polyolefin IV Bags
PVC (polyvinyl chloride) IV Bags
Others
I.V. (Intravenous Fluid) Bags Segment by Application

Veterinary Medicine
Drug Delivery
Healthcare
I.V. (Intravenous Fluid) Bags Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global I.V. (Intravenous Fluid) Bags status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions I.V. (Intravenous Fluid) Bags market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify I.V. (Intravenous Fluid) Bags significant trends, drivers, influence factors in global and regions.
6. To analyze I.V. (Intravenous Fluid) Bags competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global I.V. (Intravenous Fluid) Bags market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of I.V. (Intravenous Fluid) Bags and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of I.V. (Intravenous Fluid) Bags.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

1: Provides an overview of the I.V. (Intravenous Fluid) Bags market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
2: Analysis key trends, drivers, challenges, and opportunities within the global I.V. (Intravenous Fluid) Bags industry.
3: Detailed analysis of I.V. (Intravenous Fluid) Bags manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
6: Sales and value of I.V. (Intravenous Fluid) Bags in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
7: Sales and value of I.V. (Intravenous Fluid) Bags in country level. It provides sigmate data by type, and by application for each country/region.
8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
9: Analysis of industrial chain, including the upstream and downstream of the industry.
10: Concluding Insights.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global I.V. (Intravenous Fluid) Bags Sales Value (2020-2031)
1.2.2 Global I.V. (Intravenous Fluid) Bags Sales Volume (2020-2031)
1.2.3 Global I.V. (Intravenous Fluid) Bags Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 I.V. (Intravenous Fluid) Bags Market Dynamics
2.1 I.V. (Intravenous Fluid) Bags Industry Trends
2.2 I.V. (Intravenous Fluid) Bags Industry Drivers
2.3 I.V. (Intravenous Fluid) Bags Industry Opportunities and Challenges
2.4 I.V. (Intravenous Fluid) Bags Industry Restraints
3 I.V. (Intravenous Fluid) Bags Market by Company
3.1 Global I.V. (Intravenous Fluid) Bags Company Revenue Ranking in 2024
3.2 Global I.V. (Intravenous Fluid) Bags Revenue by Company (2020-2025)
3.3 Global I.V. (Intravenous Fluid) Bags Sales Volume by Company (2020-2025)
3.4 Global I.V. (Intravenous Fluid) Bags Average Price by Company (2020-2025)
3.5 Global I.V. (Intravenous Fluid) Bags Company Ranking (2023-2025)
3.6 Global I.V. (Intravenous Fluid) Bags Company Manufacturing Base and Headquarters
3.7 Global I.V. (Intravenous Fluid) Bags Company Product Type and Application
3.8 Global I.V. (Intravenous Fluid) Bags Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global I.V. (Intravenous Fluid) Bags Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 I.V. (Intravenous Fluid) Bags Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 I.V. (Intravenous Fluid) Bags Market by Type
4.1 I.V. (Intravenous Fluid) Bags Type Introduction
4.1.1 Polyolefin IV Bags
4.1.2 PVC (polyvinyl chloride) IV Bags
4.1.3 Others
4.2 Global I.V. (Intravenous Fluid) Bags Sales Volume by Type
4.2.1 Global I.V. (Intravenous Fluid) Bags Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global I.V. (Intravenous Fluid) Bags Sales Volume by Type (2020-2031)
4.2.3 Global I.V. (Intravenous Fluid) Bags Sales Volume Share by Type (2020-2031)
4.3 Global I.V. (Intravenous Fluid) Bags Sales Value by Type
4.3.1 Global I.V. (Intravenous Fluid) Bags Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global I.V. (Intravenous Fluid) Bags Sales Value by Type (2020-2031)
4.3.3 Global I.V. (Intravenous Fluid) Bags Sales Value Share by Type (2020-2031)
5 I.V. (Intravenous Fluid) Bags Market by Application
5.1 I.V. (Intravenous Fluid) Bags Application Introduction
5.1.1 Veterinary Medicine
5.1.2 Drug Delivery
5.1.3 Healthcare
5.2 Global I.V. (Intravenous Fluid) Bags Sales Volume by Application
5.2.1 Global I.V. (Intravenous Fluid) Bags Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global I.V. (Intravenous Fluid) Bags Sales Volume by Application (2020-2031)
5.2.3 Global I.V. (Intravenous Fluid) Bags Sales Volume Share by Application (2020-2031)
5.3 Global I.V. (Intravenous Fluid) Bags Sales Value by Application
5.3.1 Global I.V. (Intravenous Fluid) Bags Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global I.V. (Intravenous Fluid) Bags Sales Value by Application (2020-2031)
5.3.3 Global I.V. (Intravenous Fluid) Bags Sales Value Share by Application (2020-2031)
6 I.V. (Intravenous Fluid) Bags Regional Sales and Value Analysis
6.1 Global I.V. (Intravenous Fluid) Bags Sales by Region: 2020 VS 2024 VS 2031
6.2 Global I.V. (Intravenous Fluid) Bags Sales by Region (2020-2031)
6.2.1 Global I.V. (Intravenous Fluid) Bags Sales by Region: 2020-2025
6.2.2 Global I.V. (Intravenous Fluid) Bags Sales by Region (2026-2031)
6.3 Global I.V. (Intravenous Fluid) Bags Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global I.V. (Intravenous Fluid) Bags Sales Value by Region (2020-2031)
6.4.1 Global I.V. (Intravenous Fluid) Bags Sales Value by Region: 2020-2025
6.4.2 Global I.V. (Intravenous Fluid) Bags Sales Value by Region (2026-2031)
6.5 Global I.V. (Intravenous Fluid) Bags Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America I.V. (Intravenous Fluid) Bags Sales Value (2020-2031)
6.6.2 North America I.V. (Intravenous Fluid) Bags Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe I.V. (Intravenous Fluid) Bags Sales Value (2020-2031)
6.7.2 Europe I.V. (Intravenous Fluid) Bags Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific I.V. (Intravenous Fluid) Bags Sales Value (2020-2031)
6.8.2 Asia-Pacific I.V. (Intravenous Fluid) Bags Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America I.V. (Intravenous Fluid) Bags Sales Value (2020-2031)
6.9.2 South America I.V. (Intravenous Fluid) Bags Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa I.V. (Intravenous Fluid) Bags Sales Value (2020-2031)
6.10.2 Middle East & Africa I.V. (Intravenous Fluid) Bags Sales Value Share by Country, 2024 VS 2031
7 I.V. (Intravenous Fluid) Bags Country-level Sales and Value Analysis
7.1 Global I.V. (Intravenous Fluid) Bags Sales by Country: 2020 VS 2024 VS 2031
7.2 Global I.V. (Intravenous Fluid) Bags Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global I.V. (Intravenous Fluid) Bags Sales by Country (2020-2031)
7.3.1 Global I.V. (Intravenous Fluid) Bags Sales by Country (2020-2025)
7.3.2 Global I.V. (Intravenous Fluid) Bags Sales by Country (2026-2031)
7.4 Global I.V. (Intravenous Fluid) Bags Sales Value by Country (2020-2031)
7.4.1 Global I.V. (Intravenous Fluid) Bags Sales Value by Country (2020-2025)
7.4.2 Global I.V. (Intravenous Fluid) Bags Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2020-2031)
7.5.2 USA I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2024 VS 2031
7.5.3 USA I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2020-2031)
7.6.2 Canada I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2020-2031)
7.6.2 Mexico I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2020-2031)
7.8.2 Germany I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2020-2031)
7.9.2 France I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2024 VS 2031
7.9.3 France I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2020-2031)
7.10.2 U.K. I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2020-2031)
7.11.2 Italy I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2020-2031)
7.12.2 Spain I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2020-2031)
7.13.2 Russia I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2020-2031)
7.16.2 China I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2024 VS 2031
7.16.3 China I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2020-2031)
7.17.2 Japan I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2020-2031)
7.18.2 South Korea I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2020-2031)
7.19.2 India I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2024 VS 2031
7.19.3 India I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2020-2031)
7.20.2 Australia I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2020-2031)
7.22.2 Brazil I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2020-2031)
7.23.2 Argentina I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2020-2031)
7.24.2 Chile I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2020-2031)
7.25.2 Colombia I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2020-2031)
7.26.2 Peru I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2020-2031)
7.28.2 Israel I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2020-2031)
7.29.2 UAE I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2020-2031)
7.30.2 Turkey I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2020-2031)
7.31.2 Iran I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2020-2031)
7.32.2 Egypt I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Amcor
8.1.1 Amcor Comapny Information
8.1.2 Amcor Business Overview
8.1.3 Amcor I.V. (Intravenous Fluid) Bags Sales, Value and Gross Margin (2020-2025)
8.1.4 Amcor I.V. (Intravenous Fluid) Bags Product Portfolio
8.1.5 Amcor Recent Developments
8.2 Baxter
8.2.1 Baxter Comapny Information
8.2.2 Baxter Business Overview
8.2.3 Baxter I.V. (Intravenous Fluid) Bags Sales, Value and Gross Margin (2020-2025)
8.2.4 Baxter I.V. (Intravenous Fluid) Bags Product Portfolio
8.2.5 Baxter Recent Developments
8.3 Fresenius Kabi
8.3.1 Fresenius Kabi Comapny Information
8.3.2 Fresenius Kabi Business Overview
8.3.3 Fresenius Kabi I.V. (Intravenous Fluid) Bags Sales, Value and Gross Margin (2020-2025)
8.3.4 Fresenius Kabi I.V. (Intravenous Fluid) Bags Product Portfolio
8.3.5 Fresenius Kabi Recent Developments
8.4 Hospira (Pfizer)
8.4.1 Hospira (Pfizer) Comapny Information
8.4.2 Hospira (Pfizer) Business Overview
8.4.3 Hospira (Pfizer) I.V. (Intravenous Fluid) Bags Sales, Value and Gross Margin (2020-2025)
8.4.4 Hospira (Pfizer) I.V. (Intravenous Fluid) Bags Product Portfolio
8.4.5 Hospira (Pfizer) Recent Developments
8.5 ICU Medical, Inc.
8.5.1 ICU Medical, Inc. Comapny Information
8.5.2 ICU Medical, Inc. Business Overview
8.5.3 ICU Medical, Inc. I.V. (Intravenous Fluid) Bags Sales, Value and Gross Margin (2020-2025)
8.5.4 ICU Medical, Inc. I.V. (Intravenous Fluid) Bags Product Portfolio
8.5.5 ICU Medical, Inc. Recent Developments
8.6 JW Lifescience Corporation
8.6.1 JW Lifescience Corporation Comapny Information
8.6.2 JW Lifescience Corporation Business Overview
8.6.3 JW Lifescience Corporation I.V. (Intravenous Fluid) Bags Sales, Value and Gross Margin (2020-2025)
8.6.4 JW Lifescience Corporation I.V. (Intravenous Fluid) Bags Product Portfolio
8.6.5 JW Lifescience Corporation Recent Developments
8.7 Otsuka Pharmaceutical
8.7.1 Otsuka Pharmaceutical Comapny Information
8.7.2 Otsuka Pharmaceutical Business Overview
8.7.3 Otsuka Pharmaceutical I.V. (Intravenous Fluid) Bags Sales, Value and Gross Margin (2020-2025)
8.7.4 Otsuka Pharmaceutical I.V. (Intravenous Fluid) Bags Product Portfolio
8.7.5 Otsuka Pharmaceutical Recent Developments
8.8 SIPPEX
8.8.1 SIPPEX Comapny Information
8.8.2 SIPPEX Business Overview
8.8.3 SIPPEX I.V. (Intravenous Fluid) Bags Sales, Value and Gross Margin (2020-2025)
8.8.4 SIPPEX I.V. (Intravenous Fluid) Bags Product Portfolio
8.8.5 SIPPEX Recent Developments
8.9 Wihuri Group
8.9.1 Wihuri Group Comapny Information
8.9.2 Wihuri Group Business Overview
8.9.3 Wihuri Group I.V. (Intravenous Fluid) Bags Sales, Value and Gross Margin (2020-2025)
8.9.4 Wihuri Group I.V. (Intravenous Fluid) Bags Product Portfolio
8.9.5 Wihuri Group Recent Developments
8.10 B. Braun
8.10.1 B. Braun Comapny Information
8.10.2 B. Braun Business Overview
8.10.3 B. Braun I.V. (Intravenous Fluid) Bags Sales, Value and Gross Margin (2020-2025)
8.10.4 B. Braun I.V. (Intravenous Fluid) Bags Product Portfolio
8.10.5 B. Braun Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 I.V. (Intravenous Fluid) Bags Value Chain Analysis
9.1.1 I.V. (Intravenous Fluid) Bags Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 I.V. (Intravenous Fluid) Bags Sales Mode & Process
9.2 I.V. (Intravenous Fluid) Bags Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 I.V. (Intravenous Fluid) Bags Distributors
9.2.3 I.V. (Intravenous Fluid) Bags Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings